Results 71 to 80 of about 10,600 (216)

Monkeypox Virus: Epidemiology, Virology, Diagnosis, Vaccine, and Therapeutics

MedComm, Volume 7, Issue 1, January 2026.
This review provides a comprehensive overview of the latest research advances in MPXV, with a focused analysis across five core dimensions: epidemiology, virology, diagnosis, vaccine, and therapeutics. The primary objective of this review is to advance the understanding of MPXV and facilitate the development of more effective diagnostic methods ...
Yunzheng Yan, Yaqin Sun, Guangyan Sun, Cheng Niu, Xinyuan Zhao, Ming Zhao, Tongyao Liu, Suyue Zhang, Hui Zhai, Ankang Liu, Shouzhi Yu, Shuyuan Pan, Wu Zhong, Yuntao Zhang, Song Li   +14 more
wiley   +1 more source

A nanoparticle vaccine displaying varicella-zoster virus gE antigen induces a superior cellular immune response than a licensed vaccine in mice and non-human primates

Frontiers in Immunology
Herpes zoster (HZ), also known as shingles, remains a significant global health issue and most commonly seen in elderly individuals with an early exposure history to varicella-zoster virus (VZV).
Yuanyuan Li, Siyu Tian, Yuanbao Ai, Zhulong Hu, Chao Ma, Meijuan Fu, Zhenqian Xu, Yan Li, Shuyun Liu, Yongjuan Zou, Yu Zhou, Jing Jin   +11 more
doaj   +1 more source

Local CD4 and CD8 T-Cell Reactivity to HSV-1 Antigens Documents Broad Viral Protein Expression and Immune Competence in Latently Infected Human Trigeminal Ganglia [PDF]

, 2013
Herpes simplex virus type 1 (HSV-1) infection results in lifelong chronic infection of trigeminal ganglion (TG) neurons, also referred to as neuronal HSV-1 latency, with periodic reactivation leading to recrudescent herpetic disease in some persons.
AA Chentoufi, AJ St Leger, AL van Lint, Albert D. M. E. Osterhaus, Alessandro Sette, C Johnston, D Theil, David M. Koelle, DM Koelle, Georges M. G. M. Verjans, GM Verjans, GMGM Verjans, IJ De Vries, JE Knickelbein, JG Stevens, JL Umbach, K Held, K Held, Karen L. Mossman, KM Khanna, L Jing, L Jing, L Remeijer, Lichen Jing, LJ Walker, LM Wakim, LT Feldman, M van Velzen, M Wolfl, ME Wallace, MF Kramer, Monique van Velzen, PR Kinchington, PR Krause, R Vita, RB Belshe, RL Thompson, SE Straus, SE Straus, SR Pevenstein, T Derfuss, T Du, T Liu, WJ Ouwendijk, WJ Ouwendijk   +44 more
core   +4 more sources

Live Zoster Vaccination and the Reduced Risk of Chronic Respiratory Diseases: An Emulated Target Trial

Allergy, Volume 81, Issue 1, Page 209-219, January 2026.
This emulated target trial investigated the risk of developing chronic respiratory diseases (COPD, asthma, and ILD) associated with live zoster vaccination using a nationwide, population‐based cohort of individuals aged ≥ 50 years in South Korea. Live zoster vaccination significantly reduced the risk of COPD, asthma, and ILD, and reduced hospital ...
Tae Hyeon Kim, Kyeongmin Lee, Jaehyeong Cho, Jiyeon Oh, Sooji Lee, Lee Smith, Francesco Branda, Junyang Jung, Jinseok Lee, Hayeon Lee, Dong Keon Yon   +10 more
wiley   +1 more source

The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors

Vaccines, 2023
Background. The risk of herpes zoster reactivation is increased in immunocompromised patients, especially in those with immune-mediated inflammatory diseases (IMIDs) on Janus kinase inhibitor (JAKi) treatment.
Ana Esteban-Vazquez, Martina Steiner, Elisabet Castañeda, Cristina Andreu-Vazquez, Israel J. Thiussard, Angela Somodevilla, Moisés Gracia-Martínez, Rosa Sánchez-Diaz, Cristina García-Yubero, Maria Beatriz Paredes-Romero, Santiago Munoz-Fernández   +10 more
doaj   +1 more source

Differential cytokine responses following Marek's disease virus infection in chicken genotypes differing in resistance to Marek's disease [PDF]

, 2003
The production of cytokine mRNAs, in addition to viral DNA, was quantified by real-time quantitative reverse transcription-PCR (RT-PCR) (cytokines) or PCR (virus) in splenocytes during the course of Marek's disease virus (MDV) infection in four inbred ...
Davison, T F, Kaiser, Pete, Underwood, G
core   +1 more source

Herpes Zoster in Hematological Disorders: Pathogenesis, Risk Stratification, and Emerging Strategies for Prevention and Immunization

European Journal of Haematology, Volume 116, Issue 1, Page 14-22, January 2026.
ABSTRACT Background Herpes zoster (HZ), resulting from reactivation of latent varicella‐zoster virus (VZV), imposes a significant burden on immunocompromised patients, particularly those with hematological malignancies and recipients of hematopoietic stem cell transplants (HSCT).
Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Santino Caserta, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data

Современная ревматология
Patients with immune-mediated inflammatory rheumatic diseases (IIRD) are more likely to develop herpes zoster (HZ) than individuals in the general population.
N. V. Muravyova, B. S. Belov
doaj   +1 more source

Inactivation of pathogens on food and contact surfaces using ozone as a biocidal agent [PDF]

, 2003
This study focuses on the inactivation of a range of food borne pathogens using ozone as a biocidal agent. Experiments were carried out using Campylobacter jejuni, E.
Anderson, J.G., Goudie, A.C., MacGregor, S.J., Olateju, F., Rowan, N.   +4 more
core  

Global research priorities for infections that affect the nervous system [PDF]

, 2015
Infections that cause significant nervous system morbidity globally include viral (for example, HIV, rabies, Japanese encephalitis virus, herpes simplex virus, varicella zoster virus, cytomegalovirus, dengue virus and chikungunya virus), bacterial (for ...
Bangirana, Paul, Carabin, Hélène, John, Chandy C., Montano, Silvia M., Peterson, Phillip K., Zunt, Joseph R.   +5 more
core   +1 more source